From Years to Months: How AI is Shaping the Landscape of Clinical Trials
Portfolio Pulse from Vandana Singh
Pharmaceutical companies are using artificial intelligence (AI) to expedite the process of clinical trials, potentially saving time and money. Companies like Amgen Inc, Bayer AG, and Novartis AG are using AI to analyze large amounts of data. Amgen's AI tool, ATOMIC, has proven to expedite the trial enrollment process, with the company aiming to use it for most of its studies by 2024. However, concerns about potential inaccuracies when comparing non-randomized data sets remain.
September 22, 2023 | 11:49 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Amgen's AI tool, ATOMIC, is expediting the trial enrollment process, with the company aiming to use it for most of its studies by 2024.
The use of AI in speeding up the trial process could potentially save Amgen significant time and money, which could positively impact the company's bottom line.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Bayer AG is using AI to analyze large amounts of data in clinical trials.
The use of AI in analyzing data could potentially make Bayer's clinical trials more efficient, which could have a positive impact on the company's operations.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Novartis AG is using AI to analyze large amounts of data in clinical trials.
The use of AI in analyzing data could potentially make Novartis's clinical trials more efficient, which could have a positive impact on the company's operations.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80